By employing transgenic mice that specifically express FIBCD1 in the intestinal epithelium and subjecting them to AOM/DSS treatment, we demonstrate that increased FIBCD1 expression ameliorates the development of CAC. Here, FIBCD1 is linked to infectious otitis media.